Alaunos met Nasdaq's required equity level, so its shares can keep trading there and the delisting hearing is canceled. Losses, accounting changes, and other listing rules could put its listing at risk again.
This removes the immediate threat of losing its Nasdaq listing. Alaunos still warns that losses, accounting changes, needed shareholder votes, or other listing rules could put its listing at risk again.
Follow Alaunos Therapeutics, Inc. (TCRT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TCRT